产品详情
简单介绍：
Anti-Nebraska Calf Diarrhea Virus NSP4抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-Nebraska Calf Diarrhea Virus NSP4抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-Nebraska Calf Diarrhea Virus NSP4
Cat. Number:
Anti-Nebraska Calf Diarrhea Virus NSP4抗体KL-19094R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Bovine virus diarrhea (BVD) is a complicated disease to discuss as it can result in a wide variety of disease problems from very mild to very severe. BVD can be one of the most devastating diseases cattle encounter and one of theAnti-Nebraska Calf Diarrhea Virus NSP4抗体 hardest to get rid of when it attacks a herd. The viruses that cause BVD have been grouped into two genotypes, Type I and Type II. The disease syndrome caused by the two genotypes is basically the same, however disease caused by Type II infection is often more severe. The various disease syndromes noted in cattle infected with BVD virus are mainly attributed to the age of the animal when it became infected and to certain characteristics of the virus involved.
Also known as:
Non-structural glycoprotein 4;Anti-Nebraska Calf Diarrhea Virus NSP4抗体 NSP4; NSP4_ROTBN; NCVP5; NS28.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Bovine(Nebraska Anti-Nebraska Calf Diarrhea Virus NSP4抗体Calf Diarrhea Virus).
●
Immunogen: KLH conjugated synthetic peptide derived from human Nebraska Calf Diarrhea Virus.
●
Predicted Molecular Weight: 20kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-Nebraska Calf Diarrhea Virus NSP4抗体
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
